Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | Regulatory qualification for the EBMT patient registry for CAR T-cell therapy

Christian Chabannon, MD, PhD, of Institut Paoli-Calmettes, Marseille, France, discusses CAR T-cell therapy, particularly the regulatory qualification from the European Medicines Agency (EMA). Prof. Chabannon was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.